Wayner Vieira de Souza

Wayner Vieira de Souza

Auto-generated profile, based on publicly available information

Wayner Vieira de Souza

Department of Collective Health, Aggeu Magalhães Institute, Oswaldo Cruz Foundation, Recife 50740-465, Brazil

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
TAThalia Velho Barreto de Araújo
Thalia Velho Barreto de Araújo
LRLaura Cunha Rodrigues
Laura Cunha Rodrigues
RXRicardo Ximenes
Ricardo Ximenes
DMDemócrito Miranda-Filho
Demócrito Miranda-Filho
UMUlisses Ramos Montarroyos
Ulisses Ramos Montarroyos
CMCelina Maria Turchi Martelli
Celina Maria Turchi Martelli

1 March 2018 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
TAThalia Velho Barreto de Araújo
Thalia Velho Barreto de Araújo
RXRicardo Arraes de Alencar Ximenes
Ricardo Arraes de Alencar Ximenes
DMDemócrito de Barros Miranda-Filho
Demócrito de Barros Miranda-Filho
WSWayner Vieira Souza
Wayner Vieira Souza
UMUlisses Ramos Montarroyos
Ulisses Ramos Montarroyos
VOValdete Felix Oliveira
Valdete Felix Oliveira

1 March 2010 in Acta Tropica
Verified
Journal Article
Closed access
CBCYNTHIA BRAGA
CYNTHIA BRAGA
CLCarlos Feitosa Luna
Carlos Feitosa Luna
CMCelina Maria Turchi Martelli
Celina Maria Turchi Martelli
WSWayner Vieira de Souza
Wayner Vieira de Souza
MCMarli Tenório Cordeiro
Marli Tenório Cordeiro
EMErnesto T A Marques
Ernesto T A Marques

24 September 2015 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
CMCelina Maria Turchi Martelli
Celina Maria Turchi Martelli
JSJoao Bosco Siqueira
Joao Bosco Siqueira
MPMirian Perpetua Palha Dias Parente
Mirian Perpetua Palha Dias Parente
AZAna Laura de Sene Amâncio Zara
Ana Laura de Sene Amâncio Zara
COConsuelo Silva Oliveira
Consuelo Silva Oliveira
WSWayner Vieira De Souza
Wayner Vieira De Souza
Dengue is an increasing public health concern in Brazil. There is a need for an updated evaluation of the economic impact of dengue within the country. We undertook this multicenter study to evaluate the economic burden of dengue in Brazil. We estimated the economic burden of dengue in Brazil for the years 2009 to 2013 and for the epidemic season of August 2012- September 2013. We conducted a multicenter cohort study across four endemic regions: Midwest, Goiania; Southeast, Belo Horizonte and Rio de Janeiro; Northeast: Teresina and Recife; and the North, Belem. Ambulatory or hospitalized cases with suspected or laboratory-confirmed dengue treated in both the private and public sectors were recruited. Interviews were scheduled for the convalescent period to ascertain characteristics of the dengue episode, date of first symptoms/signs and recovery, use of medical services, work/school absence, household spending (out-of-pocket expense) and income lost using a questionnaire developed for a previous cost study. We also extracted data from the patients’ medical records for hospitalized cases. Overall costs per case and cumulative costs were calculated from the public payer and societal perspectives. National cost estimations took into account cases reported in the official notification system (SINAN) with adjustment for underreporting of cases. We applied a probabilistic sensitivity analysis using Monte Carlo simulations with 90% certainty levels (CL). We screened 2,223 cases, of which 2,035 (91.5%) symptomatic dengue cases were included in our study. The estimated cost for dengue for the epidemic season (2012–2013) in the societal perspective was US$ 468 million (90% CL: 349–590) or US$ 1,212 million (90% CL: 904–1,526) after adjusting for under-reporting. Considering the time series of dengue (2009–2013) the estimated cost of dengue varied from US$ 371 million (2009) to US$ 1,228 million (2013). The economic burden associated with dengue in Brazil is substantial with large variations in reported cases and consequently costs reflecting the dynamic of dengue transmission. The World Health Organization estimates that 50–100 million dengue infections occur annually. However, estimates based on cartographic modeling approaches suggest that up to 390 million dengue infections annually. Dengue has become an increasing public health concern in the Americas. A substantial number of cases in the Americas are reported in Brazil. There is a need for an updated evaluation of the economic impact of dengue in Brazil so as to allow decision/policy makers to make informed decisions on resource allocation and strategic planning. We estimated the economic burden of dengue in four regions. National cost estimates were based on the number of cases reported in Sistema de Informacao de Agravos de Notificacao (SINAN). Overall, 2,035 (91.5%) dengue cases were recruited to our study. More than 2 million suspected dengue cases and 569 deaths were reported in SINAN from September 2012 to August 2013. The annual national economic burden was US$ 164 million from the public payer perspective, but may be as high as US$ 447 million (adjusting for underreporting). From the societal perspective, the economic burden was US$ 468 million, but may be as high as US$ 1,212 million. The economic burden associated with dengue in Brazil is substantial.

4 January 2011 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
IRIsabel Rodriguez-Barraquer
Isabel Rodriguez-Barraquer
MCMarli T. Cordeiro
Marli T. Cordeiro
CBCYNTHIA BRAGA
CYNTHIA BRAGA
WSWayner V. de Souza
Wayner V. de Souza
EMErnesto T A Marques
Ernesto T A Marques
DCDerek A. T. Cummings
Derek A. T. Cummings
Dengue virus (DENV) was reintroduced into Brazil in 1986 and by 1995 it had spread throughout the country. In 2007 the number of dengue hemorrhagic fever (DHF) cases more than doubled and a shift in the age distribution was reported. While previously the majority of DHF cases occurred among adults, in 2007 53% of cases occurred in children under 15 years old. The reasons for this shift have not been determined. Age stratified cross-sectional seroepidemiologic survey conducted in Recife, Brazil in 2006. Serostatus was determined by ELISA based detection of Dengue IgG. We estimated time-constant and time-varying forces of infection of DENV between 1986 and 2006. We used discrete-time simulation to estimate the accumulation of monotypic and multitypic immunity over time in a population previously completely susceptible to DENV. We projected the age distribution of population immunity to dengue assuming similar hazards of infection in future years. The overall prevalence of DENV IgG was 0.80 (n = 1427). The time-constant force of infection for the period was estimated to be 0.052 (95% CI 0.041, 0.063), corresponding to 5.2% of susceptible individuals becoming infected each year by each serotype. Simulations show that as time since re-emergence of dengue goes by, multitypic immunity accumulates in adults while an increasing proportion of susceptible individuals and those with monotypic immunity are among young age groups. The median age of those monotypically immune can be expected to shift from 24 years, 10 years after introduction, to 13 years, 50 years after introduction. Of those monotypically immune, the proportion under 15 years old shifts from 27% to 58%. These results are consistent with the dengue notification records from the same region since 1995. Assuming that persons who have been monotypically exposed are at highest risk for severe dengue, the shift towards younger patient ages observed in Brazil can be partially explained by the accumulation of multitypic immunity against DENV-1, 2, and 3 in older age groups, 22 years after the re-introduction of these viruses. Serotype specific seroepidemiologic studies are necessary to accurately estimate the serotype specific forces of infection. The spread of dengue virus is a major public health problem. Though the burden of dengue has historically been concentrated in Southeast Asian countries, Brazil has become the country that reports the largest number of cases in the world. While prior to 2007 the disease affected mostly adults, during the 2007 epidemic the number of dengue hemorrhagic fever cases more than doubled, and over 53% of cases were in children under 15 years of age. In this paper, we propose that the conditions for the shift were being set gradually since the re-introduction of dengue in 1986 and that they represent the transition from re-emergence to hyperendemicity. Using data from an age stratified seroprevalence study conducted in Recife, we estimated the force of infection (a measure of transmission intensity) between 1986–2006 and used these estimates to simulate the accumulation of immunity since the re-emergence. As the length of time that dengue has circulated increases, adults have a lower probability of remaining susceptible to primary or secondary infection and thus, cases become on average younger. If in fact the shift represents the transition from re-emergence to hyperendemicity, similar shifts are likely to be observed in the rest of Brazil, the American continent and other regions where transmission emerges.

1 February 2008 in Memórias do Instituto Oswaldo Cruz
Verified
Journal Article
Open access
PDF file
LRLêda Regis
Lêda Regis
AMAntonio Miguel Vieira Monteiro
Antonio Miguel Vieira Monteiro
MMMaria Alice Varjal de Melo-Santos
Maria Alice Varjal de Melo-Santos
JJJosé Constantino Silveira Jr
José Constantino Silveira Jr
AFAndré Freire Furtado
André Freire Furtado
WSWayner Vieira de Souza
Wayner Vieira de Souza
A new approach to dengue vector surveillance based on permanent egg-collection using a modified ovitrap and Bacillus thuringiensis israelensis(Bti) was evaluated in different urban landscapes in Recife, Northeast Brazil. From April 2004 to April 2005, 13 egg-collection cycles of four weeks were carried out. Geo-referenced ovitraps containing grass infusion, Bti and three paddles were placed at fixed sampling stations distributed over five selected sites. Continuous egg-collections yielded more than four million eggs laid into 464 sentinel-ovitraps over one year. The overall positive ovitrap index was 98.5% (over 5,616 trap observations). The egg density index ranged from 100 to 2,500 eggs per trap-cycle, indicating a wide spread and high density of Aedes aegypti (Diptera: Culicidae) breeding populations in all sites. Fluctuations in population density over time were observed, particularly a marked increase from January on, or later, according to site. Massive egg-collection carried out at one of the sites prevented such a population outbreak. At intra-site level, egg counts made it possible to identify spots where the vector population is consistently concentrated over the time, pinpointing areas that should be considered high priority for control activities. The results indicate that these could be promising strategies for detecting and preventing Ae. aegypti population outbreaks.